Molino, Diana http://orcid.org/0000-0002-2188-3880
Durier, Christine
Radenne, Anne
Desaint, Corinne
Ropers, Jacques
Courcier, Soizic
Vieillard, Louis Victorien
Rekacewicz, Claire
Parfait, Beatrice
Appay, Victor
Batteux, Frédéric
Barillot, Emmanuel http://orcid.org/0000-0003-2724-2002
Cogné, Michel
Combadière, Béhazine
Eberhardt, Christiane S.
Gorochov, Guy http://orcid.org/0000-0003-2097-9677
Hupé, Philippe http://orcid.org/0000-0001-8468-3424
Ninove, Laetitia
Paul, Stéphane http://orcid.org/0000-0002-8830-4273
Pellegrin, Isabelle
van der Werf, Sylvie http://orcid.org/0000-0002-1148-4456
Lefebvre, Maeva
Botelho-Nevers, Elisabeth
Ortega-Perez, Inmaculada
Jaspard, Marie
Sow, Samba
Lelièvre, Jean Daniel
de Lamballerie, Xavier
Kieny, Marie Paule
Tartour, Eric http://orcid.org/0000-0002-7323-468X
Launay, Odile
Article History
First Online: 5 May 2022
Competing interests
: B.C. has been a scientific board member for Sanofi Pasteur and AstraZeneca and received personal fees as a speaker for Pfizer. E.B.-N. has been a scientific board member for Pfizer, Sanofi Pasteur and Janssen with all honoraria paid to her institution. E.T. has received personal fees as a speaker or consultant for BMS and Kephren and research grants from Servier, OSE Immunotherapeutics and Imcheck. S.v.d.V. has a provisional patent on SARS-CoV-2 diagnostics and a research grant from Sanofi Pasteur on an unrelated subject. O.L. has received personal fees from Sanofi Pasteur, grants, personal fees and non-financial support from Pfizer, Janssen, Sanofi Pasteur and Merck Sharp & Dohme, and grants and non-financial support from GlaxoSmithKline. All other authors declare no conflicts.
Free to read: This content has been made available to all.